SEARCH

SEARCH BY CITATION

References

  • Dahr SS, Cusick M, Rodriguez-Coleman H, Srivastava SK, Thompson DJ, Linehan WM, Ferris FL III & Chew EY (2007): Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina 27: 150158.
  • Kreusel KM, Bornfeld N, Lommatzsch A, Wessing A & Foerster MH (1998): Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology 105: 13861392.
  • Los M, Aarsman CJ, Terpstra L, Wittebol-Post D, Lips CJ, Blijham G & Voest EE (1997): Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease. Ann Oncol 8: 10151022.
  • McDonald HR, Schatz H, Johnson RN et al. (1996): Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment. Ophthalmology 103: 329335.
  • Wong WT, Liang KJ, Hammel K, Coleman HR & Chew EY (2008): Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease. Ophthalmology 115: 19571964.